Loading...
XJPX
4531
Market cap46mUSD
Jul 10, Last price  
371.00JPY
1D
5.10%
1Q
-2.37%
Jan 2017
46.06%
Name

Yuki Gosei Kogyo Co Ltd

Chart & Performance

D1W1MN
XJPX:4531 chart
P/E
25.62
P/S
0.52
EPS
14.48
Div Yield, %
2.55%
Shrs. gr., 5y
-0.22%
Rev. gr., 5y
6.85%
Revenues
15.45b
+2.12%
10,501,403,00010,411,013,0009,602,831,0009,322,316,0008,116,579,0008,609,017,0009,422,580,00010,005,178,00010,576,448,00010,396,051,00010,073,000,00010,272,000,00010,717,000,00011,091,000,00012,361,000,00012,839,000,00012,932,000,00015,128,000,00015,448,000,000
Net income
313m
-65.07%
261,646,000-782,875,000-567,622,000-11,963,000207,735,000337,890,00053,504,000330,209,000350,746,000355,307,000125,000,000104,000,000-42,000,000288,000,000248,000,000556,000,000776,000,000896,000,000313,000,000
CFO
2.84b
+32.71%
1,543,069,000956,097,000144,956,0001,996,218,000-386,449,0001,197,487,0001,769,209,0001,384,604,000590,572,000486,083,000687,000,000656,000,0001,420,000,000352,000,0001,787,000,000668,000,000388,000,0002,143,000,0002,844,000,000
Dividend
Mar 30, 202610 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Yuki Gosei Kogyo Co., Ltd. is a Japanese enterprise that globally researches, develops, produces, and markets sophisticated fine chemical products. Their diverse portfolio encompasses food-grade additives, pharmaceutical components, and chemicals for industrial and agricultural applications. Key offerings include glycine and its derivatives, nicotinamide, isoniazid, various drug intermediates, and cosmetic raw materials. The company also provides a range of specialized compounds, such as those based on amino acids, pyridine, piperidine, and silicon, alongside biological products like DNA, nucleosides, protamine, and active pharmaceutical ingredients (APIs). Furthermore, they offer contract manufacturing services for pharmaceutical and chemical products. Established in 1947, Yuki Gosei Kogyo Co., Ltd. is headquartered in Tokyo, Japan.
URL
https://www.yuki-gosei.co.jp/
IPO date
Oct 02, 1962
Employees
295
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT